Phase
Condition
Dyskinesias
Parkinson's Disease
Treatment
N/AClinical Study ID
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of Idiopathic Parkinson's Disease according to UK Brain Bank Criteria, Hoehnand Yahr stage 2-4
A positive response to item 14 of the UPDRS, part 2.
Age range 18-80
Ability to walk a minimum of 20 feet without assistive device and with one observedfreezing episode which may be triggered by visual cue
Letter of medical clearance by primary care physician dated within preceding 2 monthsof subject's initial active study visit.
Stable on PD medications for ≥ 3 months
Exclusion
Exclusion Criteria:
Intolerance to drug class
Mini-Mental Status Examination <26/30
No observable episodes of freezing of gait despite common visual cues
Not on stable PD medications for 3 months
Subjects who whose gait disturbance is due to other conditions not related to PD orFOG.
Current use of monoamine oxidase inhibitor (MAO-I)
Hypersensitivity to drug class
Narrow angle glaucoma
Pheochromocytoma
Severe cardiovascular disorders, i.e. patients with pre-existing conditions that wouldbe expected to deteriorate if their heart rate or blood pressure were to increase in aclinically significant manner (e.g. 15-20 mmHg increase in blood pressure or 20 beatsper minute in heart rate).
Patients with uncontrolled hypertension.
Patients with a history of symptomatic tachyarrhythmias.
Presence of uncontrolled depression and suicidal ideation.
Study Design
Connect with a study center
Medical University of South Carolina
Charleston, South Carolina 29425
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.